BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, February 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 9, 2016
View Archived Issues
Discovery of novel benzylpyrazole-based BUB1 kinase inhibitors with antitumor activity
Read More
PQR-620 is a novel potent and selective brain-penetrant inhibitor of mTORC1/2
Read More
Dimension Therapeutics and PENN enter inherited metabolic disease collaboration
Read More
Tokalas initiates phase I study of TK-216 in Ewing's sarcoma
Read More
TPX-0005, a novel multi-target inhibitor with the potential to overcome tumor resistance
Read More
BIND Therapeutics enters immuno-oncology agreement with Affilogic
Read More
VX-745 significantly improves motor and sensorial functionality in stroke model
Read More
Monoclonal antibody targeting Chikungunya virus --SVIR-001-- reduces viral load in primate model
Read More
Phase I data support further evaluation of plasma kallikrein inhibitor KVD-001
Read More
Paraza Pharma, Syros Pharmaceuticals and WuXi PharmaTech disclose CDK7 inhibitors
Read More
RegeneRx Biopharmaceuticals reports results from RGN-259 phase II/III study
Read More
Chembio updates progress in development of point-of-care diagnostic test for Zika virus in Brazil
Read More
Immunovaccine launches immunotherapy program
Read More
Esteve and PCB strengthen their collaboration for the discovery of new analgesic agents
Read More
Novo Nordisk reports pipeline highlights of first quarter 2016
Read More
Wyss Institute leads collaborators in development of paper-based diagnostic system for Zika
Read More
Ovarian cancer Consortium for Long-Term Survival receives phase II funding
Read More
Halaven receives approval in Europe for treatment of advanced liposarcoma
Read More
Baxalta launches a recombinant blood coagulant factor IX agent in Japan
Read More
New joint venture formed to focus on obtaining Chinese approval for Dance-501
Read More
Encouraging first clinical results reported for cancer gene therapy SGT-94
Read More
Intarcia Therapeutics presents ITCA-50 clinical results
Read More
Takeda partners with Gates Foundation on polio vaccine for developing countries
Read More
PureTech Health launches immuno-oncology company Vor BioPharma
Read More
Allergy Therapeutics reports topline phase II data on Pollinex Quattro Birch
Read More
